Semaglutide demonstrates efficacy in improving liver fibrosis across diverse subpopulations in part 1 of the ESSENCE trial outcomes in Asian and non-Asian populations
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.